Cargando…

Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus

Background and Aims: The management of chronic inflammatory bowel diseases in youth is challenging. We aimed to determine health literacy (HL), quality of life (QoL) and clinical outcomes in young adults from the BELgian CROhn's disease registry (BELCRO) in comparison to type 1 diabetes mellitu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carels, Constance, Wauters, Lucas, Outtier, An, Baert, Filip, Bossuyt, Peter, Colard, Arnaud, De Looze, Danny, Ferrante, Marc, Goegebuer, Alexander, Hauser, Bruno, Hilbrands, Robert, Hoffman, Ilse, Keymeulen, Bart, Paquot, Isabelle, Ruytjens, Isabelle, Simoens, Marc, Thienpont, Clara, Verreth, Annelies, Verstockt, Bram, Vermeire, Séverine, Veereman, Gigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892785/ https://www.ncbi.nlm.nih.gov/pubmed/33614555 http://dx.doi.org/10.3389/fped.2021.624416

Ejemplares similares

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
por: Verstockt, Sare, et al.
Publicado: (2021)

Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis
por: Lee, Ho-Su, et al.
Publicado: (2020)

New biologics and small molecules in inflammatory bowel disease: an update
por: Sabino, João, et al.
Publicado: (2019)

Chronic Antibiotic-Refractory Pouchitis: Management Challenges
por: Outtier, An, et al.
Publicado: (2021)

New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018)

Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon
por: Verstockt, Bram, et al.
Publicado: (2020)

Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis
por: Sudhakar, Padhmanand, et al.
Publicado: (2020)

Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD
por: Verstockt, Bram, et al.
Publicado: (2023)

Inflammatory Bowel Disease (IBD)—A Textbook Case for Multi-Centric Banking of Human Biological Materials
por: Cleynen, Isabelle, et al.
Publicado: (2019)

Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression
por: Sudhakar, Padhmanand, et al.
Publicado: (2022)

Off-label use of orphan medicinal products: a Belgian qualitative study
por: Dooms, Marc, et al.
Publicado: (2016)

Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA Representatives
por: van Overbeeke, Eline, et al.
Publicado: (2020)

Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice
por: Janssens, Rosanne, et al.
Publicado: (2018)

Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
por: Vandenplas, Yannick, et al.
Publicado: (2022)

Financial based agreements and performance based agreements: the Belgian experience
por: Pauwels, Kim, et al.
Publicado: (2015)

Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study
por: De Weerdt, Elfi, et al.
Publicado: (2017)

Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians
por: Barbier, Liese, et al.
Publicado: (2021)

What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population
por: Pauwels, Kim, et al.
Publicado: (2019)

Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study
por: Abdallah, Khadidja, et al.
Publicado: (2022)

Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways
por: Prins, Marileen M., et al.
Publicado: (2021)

Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases
por: Kantasiripitak, Wannee, et al.
Publicado: (2022)

Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease
por: Verstockt, Bram, et al.
Publicado: (2019)

Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases
por: Verstockt, Bram, et al.
Publicado: (2020)

Mucosal IL13RA2 expression predicts nonresponse to anti‐TNF therapy in Crohn's disease
por: Verstockt, Bram, et al.
Publicado: (2019)

Assessment of Methodological Quality of Economic Evaluations in Belgian Drug Reimbursement Applications
por: Simoens, Steven
Publicado: (2013)

Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?
por: Jacobs, Inge, et al.
Publicado: (2021)

Microbiota, not host origin drives ex vivo intestinal epithelial responses
por: Arnauts, Kaline, et al.
Publicado: (2022)

067 BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases
por: Hillary, T., et al.
Publicado: (2021)

By Belgians for Belgians
por: Childers, M. A.
Publicado: (1915)

Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015–20: a surveillance study
por: Fischer, Natalie, et al.
Publicado: (2021)

Using provocative design to foster electronic informed consent innovation
por: De Sutter, Evelien, et al.
Publicado: (2022)

Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
por: Alsoud, Dahham, et al.
Publicado: (2022)

Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease
por: Verstockt, Bram, et al.
Publicado: (2018)

SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study – the BELCOMID study
por: Geldof, Jeroen, et al.
Publicado: (2023)

The Influence of Neocate in Paediatric Short Bowel Syndrome on PN Weaning
por: De Greef, E., et al.
Publicado: (2010)

Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All
por: Sudhakar, Padhmanand, et al.
Publicado: (2022)

Genetic Influences on the Development of Fibrosis in Crohn’s Disease
por: Verstockt, Bram, et al.
Publicado: (2016)

The Belgian Association for Psychological Sciences: 75th Anniversary
por: Brysbaert, Marc
Publicado: (2022)

A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease
por: Aardoom, Martine A., et al.
Publicado: (2019)

Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium
por: Creyns, Brecht, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_47t7026dpoc0b9tc3vsdvi3fq4